Pulse of the industry: medical technology
Medtech has fared better than most industries amid the global economic downturn, but it hasn’t been entirely immune to its effects. Last year’s whopping growth rate of 11% for both the US and European medical technology markets and then flattening out in the first half of 2009 made this abundantly clear.
As long-term challenges remain, many question how the industry will contend with its ongoing funding drought and a more uncertain global regulatory and reimbursement environment. In Pulse of the industry: medical technology report 2009, we offer an inside look at the industry’s performance with intricate analysis of financial performance, financing and transaction activity in the US, European and Israeli medtech markets.
We also reveal key findings and offer a fresh perspective into the most pressing challenges and opportunities facing the industry today, including:
- The potential changes to 510(k) marketing clearance process used by the FDA
- Implications of possible changes resulting from US healthcare reform and the Physician Payment Sunshine Act of 2
- Uncertainty over reimbursement in the US market
- US healthcare reform and its expected impact on the global medtech industry on a whole
- Growth factors, including an aging global population, expanded elective/lifestyle medicine, an expanded pool of patients in the US and emerging markets, and new product innovations and improvements
Download a copy of Pulse of the industry
What’s in store for the remainder of 2009? See critical insights into this extraordinarily diverse industry, strategic considerations companies are evaluating today in an effort to advance their business models and steps they must take in order to achieve long-term success by downloading Pulse of the industry: medical technology report 2009 (pdf, 1.4mb)
